影像组学在肺癌诊断、管理及未来前景中的应用
本综述探讨影像组学在肺癌诊断与管理中的作用,方法涵盖手工影像组学至深度学习技术。重点介绍结节检测、组织学预测和疾病分期等应用,人工智能模型显示出更高的特异度和敏感度。未来方向强调大语言模型、可解释人工智能和超分辨率成像技术的整合。
要点
- 影像组学涵盖手工特征提取与深度学习,可捕捉生物学复杂性。
- 人工智能模型在肺结节检测、组织学预测和分期中显示更高特异度和敏感度。
- 未来方向包括大语言模型、可解释人工智能与超分辨率成像的整合。
核心结论
- 影像组学通过融合多源数据并将可解释性纳入人工智能模型,有望重新定义临床工作流程,为肺癌诊断、治疗计划和结局预测提供更稳健可靠的工具有助于精准肿瘤学。
研究设计与样本
- 综述,探讨影像组学在肺癌诊断与管理中的作用,方法范围从手工影像组学到深度学习技术。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
Lung cancer remains the leading cause of cancer-related mortality worldwide, with its early detection and effective treatment posing significant clinical challenges. Radiomics, the extraction of quantitative features from medical imaging, has emerged as a promising approach for enhancing diagnostic accuracy, predicting treatment responses, and personalising patient care. This review explores the role of radiomics in lung cancer diagnosis and management, with methods ranging from handcrafted radiomics to deep learning techniques that can capture biological intricacies. The key applications are highlighted across various stages of lung cancer care, including nodule detection, histology prediction, and disease staging, where artificial intelligence (AI) models demonstrate superior specificity and sensitivity. The article also examines future directions, emphasising the integration of large language models, explainable AI (XAI), and super-resolution imaging techniques as transformative developments. By merging diverse data sources and incorporating interpretability into AI models, radiomics stands poised to redefine clinical workflows, offering more robust and reliable tools for lung cancer diagnosis, treatment planning, and outcome prediction. These advancements underscore radiomics' potential in supporting precision oncology and improving patient outcomes through data-driven insights.
引用
- Boubnovski Martell M, Linton-Reid K, Chen M, et al. Radiomics for lung cancer diagnosis, management, and future prospects. Clin Radiol. 2025. PMID: 40344812. doi:10.1016/j.crad.2025.106926
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。